The results showed that LPL is still under-expressed in tumor cells and that SFRP2 is overexpressed in all HER2, Luminal A, and Luminal B subtype groups, and under-expressed in the Basal_like subtype group. This evidence concerns the gene ERBB2 and neoplasm.